Please assess the completion status of the following clinical trial:

Trial Title: The Standard Care Versus Celecoxib Outcome Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects 60 years or over Male \& Female~* Chronic NSAIDs use for 90 days or more in a 12 month period~* Subjects who have a licensed indication for chronic non-selective NSAID or Celecoxib.~* Eligible for treatment with either Celecoxib or alternative traditional non-selective NSAID.~* Subjects who are willing to consent to their paper and electronic medical records and prescribing data to be accessed.~* Subjects who are willing to be contacted and interviewed by trial investigators.~Exclusion Criteria:~* Established cardiovascular disease including ischaemic heart disease, Myocardial Infarction, angina or acute coronary syndrome, cerebrovascular disease or cerebrovascular accident or transient ischaemic attack, established peripheral vascular disease and moderate to severe heart failure.

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Celecoxib (Type: EXPERIMENTAL): Celecoxib. Celebrex 200-400mg daily in divided doses
- Diclofenac (Type: ACTIVE_COMPARATOR): continue usual nsNSAID

Based on this trial design, predict the completion outcome and termination type (if applicable).